CytoMed Therapeutics Limited Other Expense By Function
CytoMed Therapeutics Limited (GDTC) reported Other Expense By Function of SGD 1.67 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OtherExpenseByFunction · last filed 2026-03-31
SGD
| Period end | Other Expense By Function 12 month |
|---|---|
| 2025-12-31 | 1.67M SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 998.05K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 2.21M SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 494.68K SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | 518.77K SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | 127.99K SGD 20-F · filed 2023-05-01 |
USD
| Period end | Other Expense By Function 12 month |
|---|---|
| 2025-12-31 | $1.30M 20-F · filed 2026-03-31 |
| 2024-12-31 | $730.53K 20-F · filed 2025-04-28 |
| 2023-12-31 | $1.68M 20-F · filed 2024-04-22 |
| 2022-12-31 | $369.05K 20-F · filed 2023-05-01 |